This broad spectrum of potential health benefits conferred throughout the life of the human host has prompted the adoption of the colloquial moniker for this strain, "BLIS K12 – the probiotic ...

Some strains produce multiple bacteriocins, sometimes referred to as anticompetitor molecules or bacteriocin-like inhibitory substances (BLIS). S. salivarius K12 The prototype oral probiotic ...

Blis Technologies [NZX: BLT], the probiotics manufacturer ... it cited Health Canada approvals for specific label claims on products containing its BLIS K12 formula, higher sales from its North ...

BLIS Technologies Ltd is engaged in developing oral probiotics. The company markets strains of probiotic bacteria BLIS K12, BLIS Q24, and BLIS M18 which occur naturally in the oral cavity. Its product ...